Back to Search
Start Over
Is a targeted biopsy-only approach for prostate cancer diagnosis ready for the prime time?
- Source :
- Nature Reviews Urology. 18:75-76
- Publication Year :
- 2020
- Publisher :
- Springer Science and Business Media LLC, 2020.
-
Abstract
- The PRECISION trial demonstrated the ability of using multiparametric MRI to improve the diagnosis of clinically significant prostate cancer whilst reducing over-diagnosis of clinically insignificant cancer compared with systematic biopsy. Concerns remained about patients who were not biopsied owing to negative scans. A new study applies the PRECISION strategy to a contemporary cohort to answer these concerns.
- Subjects :
- Male
0301 basic medicine
medicine.medical_specialty
business.industry
Biopsy
Urology
MEDLINE
Prostatic Neoplasms
Multiparametric MRI
medicine.disease
Targeted biopsy
03 medical and health sciences
Prostate cancer
030104 developmental biology
0302 clinical medicine
030220 oncology & carcinogenesis
Cohort
Insignificant cancer
medicine
Humans
Radiology
business
Systematic biopsy
Subjects
Details
- ISSN :
- 17594820 and 17594812
- Volume :
- 18
- Database :
- OpenAIRE
- Journal :
- Nature Reviews Urology
- Accession number :
- edsair.doi.dedup.....b92ac520864bc9d921ded250155d801a